Bio-Rad Laboratories Inc. (BIO)
NYSE: BIO
· Real-Time Price · USD
285.79
-1.42 (-0.49%)
At close: Aug 15, 2025, 3:59 PM
285.66
-0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT
Bio-Rad Laboratories Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 369.3M | 521.4M | 488.1M | 410.38M | 406.91M | 433.28M | 403.81M | 457.85M | 390M | 464.14M | 434.21M | 517.94M | 596.58M | 802.32M | 470.78M | 859.9M | 732.84M | 673.47M |
Short-Term Investments | 1B | 1.14B | 1.18B | 1.21B | 1.21B | 1.21B | 1.2B | 1.3B | 1.33B | 1.39B | 1.36B | 1.33B | 1.37B | 1.27B | 399.13M | 477.2M | 428.56M | 346.4M |
Long-Term Investments | 5.58B | 4.99B | 4.84B | 6B | 5.1B | 8.02B | 7.7B | 7.22B | 7.31B | 8.88B | 8.83B | 7.46B | 8.09B | 9.69B | 14.39B | 16.23B | 11.58B | 10.5B |
Other Long-Term Assets | 107.9M | 103.7M | 101.9M | 103.62M | 98.19M | 92.87M | 94.85M | 98.47M | 100.06M | 95.51M | 94.6M | 101.77M | 100.89M | 103.92M | 104.19M | 106.63M | 99.07M | 92.19M |
Receivables | 469.9M | 424.7M | 452.5M | 461.94M | 445.51M | 444.81M | 489.02M | 457.4M | 491.57M | 498.27M | 494.64M | 432.3M | 450.32M | 464.11M | 423.54M | 417.71M | 399.31M | 408.14M |
Inventory | 798.8M | 790.1M | 760M | 804.28M | 803.69M | 783.37M | 780.52M | 775.82M | 776.6M | 752.94M | 719.32M | 685.85M | 657.13M | 605.49M | 572.24M | 588.91M | 598.99M | 605.16M |
Other Current Assets | 19M | 36M | 30.7M | 33.72M | 37.94M | 44.34M | 31.61M | 30.65M | 25.36M | 53.75M | 29.16M | 24.68M | 44.05M | 33.69M | 15.65M | 17.97M | 18.8M | 31.89M |
Total Current Assets | 2.81B | 3.04B | 3.03B | 3.06B | 3.06B | 3.06B | 3.05B | 3.15B | 3.14B | 3.28B | 3.16B | 3.14B | 3.25B | 3.3B | 1.99B | 2.47B | 2.29B | 2.18B |
Property-Plant & Equipment | 740.1M | 681.7M | 688.6M | 719.17M | 715.24M | 711.28M | 723.73M | 711.4M | 687.93M | 680.55M | 679.55M | 632.7M | 656.47M | 684.2M | 716.44M | 680.84M | 672.23M | 678.94M |
Goodwill & Intangibles | 978.5M | 710.7M | 704.1M | 722.4M | 719.2M | 726.4M | 734.1M | 721.2M | 740.2M | 735.6M | 738.6M | 724.7M | 587M | 592.8M | 601.2M | 469M | 476.8M | 483.7M |
Total Long-Term Assets | 7.4B | 6.49B | 6.33B | 7.55B | 6.63B | 9.55B | 9.25B | 8.75B | 8.84B | 10.39B | 10.34B | 8.92B | 9.43B | 11.07B | 15.81B | 17.49B | 12.83B | 11.76B |
Total Assets | 10.21B | 9.53B | 9.36B | 10.6B | 9.69B | 12.61B | 12.3B | 11.9B | 11.98B | 13.67B | 13.5B | 12.06B | 12.68B | 14.37B | 17.8B | 19.95B | 15.12B | 13.93B |
Account Payables | 139.3M | 137.9M | 122.3M | 122.19M | 126.69M | 102.75M | 144.63M | 111.86M | 149.53M | 160.98M | 135.04M | 142.75M | 158.26M | 160.65M | 141.94M | 136.4M | 133.46M | 138.49M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52.21M | n/a | n/a | n/a | 50.85M | n/a | n/a | n/a |
Short-Term Debt | 1.3M | 1.2M | 1.2M | 1.26M | n/a | n/a | 486K | n/a | 476K | 519K | 465K | n/a | n/a | 504K | 489K | 1.2M | 1.2M | 1.2M |
Other Current Liabilities | 175M | 131.7M | 147.2M | 142.01M | 149.92M | 142.43M | 161.62M | 147.8M | 166.24M | 167.2M | 117.44M | 171.75M | 212.68M | 211.09M | 127.94M | 177.76M | 154.98M | 166.5M |
Total Current Liabilities | 548.9M | 506.6M | 467.8M | 497.94M | 486.96M | 466.15M | 522.8M | 558.18M | 581.98M | 589.62M | 568.71M | 570.68M | 613.71M | 648.33M | 680.94M | 649.92M | 587.05M | 609.89M |
Long-Term Debt | 1.2B | 1.2B | 1.2B | 1.2B | 1.19B | 1.19B | 1.2B | 1.19B | 1.2B | 1.2B | 1.2B | 1.19B | 1.19B | 1.19B | 10.51M | 10.64M | 10.78M | 10.9M |
Other Long-Term Liabilities | 209.6M | 173.1M | 177.2M | 197.59M | 193.56M | 192.4M | 195.06M | 186.13M | 202.29M | 199.25M | 195.93M | 205.06M | 176.86M | 180.13M | 182.19M | 203.69M | 207.94M | 217.97M |
Total Long-Term Liabilities | 2.54B | 2.34B | 2.33B | 2.62B | 2.42B | 3.09B | 3.04B | 2.92B | 2.95B | 3.31B | 3.32B | 3.03B | 3.15B | 3.54B | 3.43B | 3.97B | 2.94B | 2.71B |
Total Liabilities | 3.09B | 2.85B | 2.79B | 3.12B | 2.91B | 3.56B | 3.56B | 3.48B | 3.53B | 3.9B | 3.89B | 3.6B | 3.76B | 4.19B | 4.11B | 4.62B | 3.52B | 3.32B |
Total Debt | 1.41B | 1.37B | 1.37B | 1.39B | 1.39B | 1.4B | 1.41B | 1.41B | 1.38B | 1.38B | 1.39B | 1.38B | 1.39B | 1.4B | 223.38M | 235.82M | 222.8M | 231.06M |
Common Stock | n/a | n/a | n/a | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | 7.8B | 7.48B | 7.42B | 8.13B | 7.48B | 9.64B | 9.26B | 8.91B | 8.8B | 9.97B | 9.9B | 9.05B | 9.21B | 10.14B | 13.53B | 15.08B | 11.16B | 10.25B |
Comprehensive Income | -154.1M | -409.8M | -538.2M | -315.27M | -451.36M | -425.97M | -336.04M | -497.56M | -372.86M | -408.35M | -466.82M | -845.21M | -533.39M | -307.86M | -175.55M | -63.04M | 125.17M | 68.43M |
Shareholders Equity | 7.13B | 6.68B | 6.57B | 7.49B | 6.78B | 9.05B | 8.74B | 8.42B | 8.45B | 9.76B | 9.62B | 8.45B | 8.92B | 10.18B | 13.69B | 15.33B | 11.59B | 10.61B |
Total Investments | 6.58B | 6.13B | 6.02B | 7.21B | 6.31B | 9.23B | 8.9B | 8.52B | 8.64B | 10.27B | 10.19B | 8.79B | 9.46B | 10.96B | 14.79B | 16.71B | 12.01B | 10.85B |